glp 1 drugs for inflammation Health Feed GLP-1 medication side effects for
Description
10.2337/db11-0227 38 FarrO
Interestingly, GLP-2 administration leads to a reduction in PTH levels in people with an intact intestine, but not in those with short bowel syndrome, 63 indicating that an intact small intestine is required for GLP-2 mediated suppression of PTH secretion
Indications for sitagliptin include use in type 2 diabetes as monotherapy or in combination with metformin or thiazolidinediones
In the CNS, endogenous GLP-1 acts primarily through vagal afferent signaling, transmitting information from the gastrointestinal tract to the brainstem [123, 124]
Rondanelli M, Perna S, Riva A, Petrangolini G, Di Paolo E, Gasparri C
